Filing Details
- Accession Number:
- 0000899243-22-027386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-02 16:16:12
- Reporting Period:
- 2022-07-29
- Accepted Time:
- 2022-08-02 16:16:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-29 | 99 | $276.65 | 5,804 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-29 | 200 | $277.95 | 5,604 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-29 | 160 | $279.28 | 5,444 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-29 | 99 | $280.22 | 5,345 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-29 | 58 | $281.03 | 5,287 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-29 | 5 | $282.34 | 5,282 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
- Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $276.65 (range $276.21 to $276.83).
- Open market sales reported on this line occurred at a weighted average price of $277.95 (range $277.63 to $278.35).
- Open market sales reported on this line occurred at a weighted average price of $279.28 (range $278.86 to $279.83).
- Open market sales reported on this line occurred at a weighted average price of $280.22 (range $279.88 to $280.78).
- Open market sales reported on this line occurred at a weighted average price of $281.03 (range $280.93 to $281.08).
Billionaire Hedge Funds
